Trikafta vs Pomalyst
Side-by-side drug price comparison from Medicare Part D data
Verdict
Trikafta costs 19% less per claim than Pomalyst ($13935.00 vs $17250.00). Trikafta has a generic alternative available. Total Medicare spending: Trikafta at $3.5B vs Pomalyst at $3.3B.
| Metric | Trikafta | Pomalyst |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $13,935* | $17,250 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $3.5B | $3.3B |
| Total Claims | 248,000 | 192,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 18.4% | 4.7%* |
| Generic Available | Yes | No |
| Condition | Cystic Fibrosis | Cancer |
| Total Beneficiaries | 18,000 | 18,000 |
Trikafta costs 19% less per claim than Pomalyst ($13935.00 vs $17250.00). Trikafta has a generic alternative available. Total Medicare spending: Trikafta at $3.5B vs Pomalyst at $3.3B.